Bivalirudin for cardiopulmonary bypass



Hypersensitivity reactions to heparin and heparin-like compounds are rare. Management of this rare condition for patients requiring cardiopulmonary bypass (CPB) represents therapeutic challenges. An alternative anticoagulant to heparin is required in the aforementioned patients.

Copyright © 2020 Terumo India Private limited

X
Important information regarding

By using this website, you consent to the use of cookies in accordance with our